You are here

Pfizer

BioNTech's COVID vaccine sales are poised to slip, but the shot will remain a 'cash cow' in the long term: analysts

BioNTech's COVID vaccine sales are poised to slip, but the shot will remain a 'cash cow' in the long term: analysts

Fierce Pharma

Flag link:

Pfizer hit with racial discrimination lawsuit over minority fellowship program

Pfizer hit with racial discrimination lawsuit over minority fellowship program

Fierce Pharma

racial discrimination

Flag link:

Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms

Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms

Fierce Pharma

Flag link:

Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel

Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel

Seeking Alpha

Moderna Therapeutics

Flag link:

Prometheus takes on Pfizer in inflammatory bowel diseases

Prometheus takes on Pfizer in inflammatory bowel diseases

EP Vantage

Prometheus Biosciences

inflammatory bowel disease

Flag link:

Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine

Striving for 2023 launch, Pfizer touts topline PhIII win for another mass market vaccine

Endpoints

meningococcal disease

clinical trials

Flag link:

Pfizer and Strata expand clinical partnership for cancer trial

Pfizer and Strata expand clinical partnership for cancer trial

Clinical Trials Arena

Strata Oncology

clinical trials

Flag link:

Racing Moderna, Pfizer starts phase 3 trial of mRNA flu vaccine

Racing Moderna, Pfizer starts phase 3 trial of mRNA flu vaccine

Fierce Biotech

Moderna Therapeutics

clinical tirals

Flag link:

Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape

Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape

Fierce Biotech

clinical trials

Flag link:

ESMO: It’s early days for Pfizer’s EZH2 inhibitor, but there’s a glimpse of hope for some

ESMO: It’s early days for Pfizer’s EZH2 inhibitor, but there’s a glimpse of hope for some

Fierce Biotech

EZH2 inhibitors

Flag link:

Ian Read named Chairman of the Board of Areteia Therapeutics

Ian Read named Chairman of the Board of Areteia Therapeutics

BioSpace

Areteia Therapeutics

Flag link:

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies

Stat

Flag link:

CDC recommends updated Covid-19 boosters

CDC recommends updated Covid-19 boosters

Stat

Omicron variant

Moderna Therapeutics

Flag link:

FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

Stat

Moderna Therapeutics

Omicron variant

Flag link:

Pfizer invests $500K in decentralized collective focused on longevity R&D

Pfizer invests $500K in decentralized collective focused on longevity R&D

Pharma Live

Flag link:

Pfizer, Moderna bivalent COVID booster nods could land this week: report

Pfizer, Moderna bivalent COVID booster nods could land this week: report

Fierce Pharma

Moderna Therapeutics

Omicron variant

Flag link:

Kymera’s pain could be Priovant’s gain

Kymera’s pain could be Priovant’s gain

EP Vantage

hidradenitis suppurativa

Flag link:

Could This Move by Moderna Cost Pfizer Billions?

Could This Move by Moderna Cost Pfizer Billions?

Motley Fool

Flag link:

Moderna sues Pfizer, BioNTech over COVID-19 vaccine technology

Moderna sues Pfizer, BioNTech over COVID-19 vaccine technology

BioPharma Dive

Moderna Therapeutics

Flag link:

Revealed: which pharma companies leading the way in artificial intelligence

Revealed: which pharma companies leading the way in artificial intelligence

Clinical Trials Arena

artificial intelligence

Johnson & Johnson

Bristol Myers Squibb

Flag link:

Pages